76

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma

Sku: 0000653

Be the first to review this product

Quick Overview

by Murphy, Michael J. (Ed.)
Publisher: Springer

ISBN: 978-1-60761-432-6
Volumes: 1
# Pages: 322

Quantity

€197.59

Categories : Pathology

I prezzi, le informazioni possono subire variazioni senza nessun preavviso. I tempi di consegna possono variare in base alla disponibilità.
All product information and prices are subject to change without notice. Delivery times may vary depending on availability.

This book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development. A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined. As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers.

Reviews

There are no reviews yet.

Be the first to review “Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma”

Top